What Is Cold Sepsis? Signs, Risks, and Treatment

Cold sepsis causes the body to shut down blood flow rather than fever up. Learn how to recognize it, why it’s dangerous, and how it’s treated.

Cold sepsis refers to sepsis that presents with an abnormally low body temperature rather than the expected fever. Most people associate infection with a rising thermometer, but in a meaningful subset of sepsis cases the body temperature drops below 36.0°C (96.8°F), a state clinicians call hypothermia. This presentation carries a higher mortality risk than febrile sepsis and is more likely to be missed, making it one of the more dangerous ways a severe infection can unfold.

How Cold Sepsis Differs From the Textbook Picture

When infection triggers the body’s immune alarm, the classic response includes fever, elevated heart rate, rapid breathing, and an abnormal white blood cell count. These formed the basis of the older systemic inflammatory response syndrome (SIRS) criteria, and the threshold for hypothermia in those criteria was a temperature below 36.0°C. In practice, “cold sepsis” is not a separate disease. It is the same dysregulated immune response to infection, but the thermoregulatory outcome is flipped: instead of spiking a fever, the patient’s core temperature drifts downward. Some studies define the cutoff as a temperature below 36.0°C sustained for more than two hours, with at least one reading at or below 35.5°C.

The trouble is that most screening tools and bedside intuitions are built around fever. When a patient arrives confused, weak, and cool to the touch, the immediate thought often goes to environmental exposure or medication effects rather than raging infection. That cognitive gap is a major reason cold sepsis is recognized later, treated later, and associated with worse outcomes.

Why the Body Goes Cold Instead of Hot

Fever and hypothermia during sepsis are not opposites in the way you might think. Research suggests they sit on the same physiological spectrum, with the direction of the temperature swing depending largely on how severe the infection is and how much metabolic reserve the patient has. In animal models, the same bacterial toxin that causes fever in a warm environment causes hypothermia in a cool one, because sepsis can widen the temperature range the brain tolerates before activating heat-generating defenses. The body essentially enters a state where its thermostat becomes loose, and ambient temperature exerts an outsized influence.

What makes this finding striking is that the body’s heat-producing machinery is not broken. Animal studies have shown that even during endotoxin-induced hypothermia, heat-generating pathways can still be activated by the right chemical signal. The suppression of thermogenesis appears to be an active choice by the brain, not an inability. Oxygen consumption drops sharply during this hypothermic state, resembling the metabolic slowdown seen in animals entering torpor rather than accidental cold exposure. Some researchers interpret this as a last-resort energy-conservation strategy: when the immune battle is overwhelming, generating a fever becomes metabolically expensive, and the body may be downshifting to preserve whatever fuel remains.

Sepsis severity seems to matter. In experimental models, more severe infection produces higher levels of prostaglandin E2 in the brain’s temperature-control center, yet the thermal response can still tip toward hypothermia rather than fever when metabolic reserves are depleted or ambient conditions are cool. The upshot is that cold sepsis often signals a more exhausted, more overwhelmed host response, which is a key reason it correlates with poorer outcomes.

The Immune Storm Beneath the Cold Surface

It is tempting to think that a hypothermic patient has a weaker inflammatory response, but the reality is messier. Sepsis is now understood to involve both hyperinflammation and immunosuppression happening simultaneously, sometimes from the very earliest stages. In cold sepsis, there is evidence that the immunosuppressive side of this equation may be more dominant. Patients who are hypothermic within the first 24 hours of sepsis diagnosis tend to develop persistent lymphopenia, a sustained drop in key immune cells that leaves the body vulnerable to secondary infections.

This matters because lymphopenia during sepsis is not just a lab curiosity. It reflects a state sometimes called immune paralysis, where the exhausted immune system can no longer mount an effective response to the original infection or to new invaders. The cold temperature itself may contribute to this: lower body temperature alters how enzymes and immune signaling molecules function, though the degree to which the hypothermia causes immune dysfunction versus simply accompanies it is still debated.

Who Is Most Likely to Develop Cold Sepsis

Anyone with sepsis can develop hypothermia, but several groups are significantly more vulnerable. Age sits at the top of the list, at both extremes.

Older adults produce fewer fever-generating inflammatory signals and tend to have lower baseline body temperatures. Reduced muscle mass limits heat production, while lower fat stores and blunted blood-vessel constriction increase heat loss. Comorbidities common in older age, such as stroke, can directly impair the brain’s thermoregulatory circuits. The result is that sepsis in an elderly patient may present with a normal or low temperature, confusing clinicians who expect a fever to signal infection.

At the other end of the age spectrum, very young infants, particularly those under 60 days old, can present with hypothermia as their primary sign of serious bacterial infection. Their immature thermoregulatory systems and relatively large body surface area make them prone to heat loss. Premature birth, low birth weight, and young age within that first two months all make hypothermia more likely to be the presenting finding. In these infants, roughly 2% of those evaluated for hypothermia turn out to have a serious bacterial infection, which sounds small until you consider that missing sepsis in a newborn is a life-or-death error.

Beyond age, immunocompromised patients, people with chronic kidney or liver disease, those on immunosuppressive medications, and patients who are malnourished or debilitated all face higher risk. Alcohol use disorders and certain endocrine conditions also blunt the febrile response, making cold presentations more common.

Recognizing Cold Sepsis Without the Usual Red Flags

Fever is such a reliable trigger for clinical concern that its absence can paradoxically delay life-saving treatment. In vulnerable populations, sepsis without classic signs is a well-documented diagnostic trap. Patients may show up with confusion, generalized weakness, malaise, or the deterioration of a single organ system without the expected fever or obvious drop in blood pressure. A subtle decline in mental status, new difficulty walking, or unexplained worsening of a chronic condition may be the only outward clue.

When temperature is low, other signs become especially important to catch. These include:

  • Cool, mottled skin: particularly on the knees, toes, and fingertips, reflecting poor peripheral blood flow.
  • Altered mental status: confusion, lethargy, or agitation that cannot be explained by other causes.
  • Rapid heart rate or breathing: the body often compensates for falling blood pressure with a faster pulse and faster breaths even when temperature is low.
  • Elevated lactate: a blood test reflecting tissue oxygen deprivation, which tends to correlate with the severity of circulatory failure.
  • Delayed capillary refill: pressing a fingernail bed and watching how long it takes for color to return can give a quick bedside clue about perfusion.

Temperature gradients between the body’s core and its extremities offer a particularly useful window in cold sepsis. Research using infrared thermography has shown that larger gaps between core temperature and peripheral sites like the knee or great toe predict worse outcomes. A core-to-knee gradient above roughly 8.85°F on arrival was correlated with seven-day mortality, and a core-to-index-finger gradient correlated with the need for blood-pressure-supporting medications within 48 hours. A cold hand paired with a warm core is not just a sign of poor circulation; it may be one of the earliest visible indicators of septic shock developing.

Mortality and Prognosis

The numbers are sobering. In a large multicenter study of sepsis patients, the 90-day mortality rate in the hypothermia group was about 28%, compared to roughly 21% for patients with normal temperatures and 15% for those who mounted a fever. That gap held regardless of age, though the absolute mortality rates shifted upward in patients over 75. Being hypothermic during sepsis, in other words, is an independent predictor of death, not just a marker of being sicker to begin with.

The finding that even normal-temperature sepsis carried higher mortality than febrile sepsis is worth noting. It suggests that the ability to generate a fever may be a sign of a more robust immune response, and its absence, whether the patient is hypothermic or simply normothermic, may signal a host that is less equipped to fight the infection.

Treatment Priorities

Cold sepsis is treated with the same core principles as any sepsis: early antibiotics, fluid resuscitation, source control (finding and addressing the origin of infection), and vasopressors when blood pressure remains dangerously low. The Surviving Sepsis Campaign bundles, which set time targets for these interventions, apply equally to hypothermic patients. In multicenter data from real-world practice, median time to first antibiotic administration was about two hours, and vasopressor initiation happened around 40 minutes after being indicated, though these numbers varied widely across hospitals. For cold sepsis, the concern is that the atypical presentation pushes those timelines later, because the diagnosis itself is delayed.

Several treatment considerations are specific to or amplified by hypothermia:

  • Active warming: gentle external rewarming (warm blankets, forced-air warming devices) is standard. Aggressive rewarming is approached carefully because rapid temperature changes can destabilize heart rhythm and blood pressure.
  • Antibiotic dosing challenges: sepsis alters how the body handles drugs. Capillary leak and fluid resuscitation expand the volume of distribution, while organ dysfunction changes how quickly drugs are cleared. Hypothermia compounds these shifts, making drug levels unpredictable and raising the risk of underdosing or toxicity.
  • Hormonal disruptions: sepsis can trigger insulin resistance, impaired cortisol production, and reduced vasopressin output, all of which affect blood sugar control and vascular tone. These endocrine problems may be especially relevant in hypothermic patients whose metabolic reserves are already strained.
  • Cardiac dysfunction: sepsis directly impairs heart muscle function through microvascular damage, suppressed receptor sensitivity, and mitochondrial energy depletion. Hypothermia adds its own strain on the cardiovascular system, making careful hemodynamic monitoring essential.

Complications of Hypothermia During Sepsis

One underappreciated risk of significant hypothermia involves blood clotting. Below roughly 32°C, the normal two-stage process of platelet clumping becomes impaired. The irreversible second phase of aggregation stalls, and platelets clump only loosely. When the patient is rewarmed, those loosely attached platelets fall apart and then may re-aggregate in a delayed surge, a phenomenon called delayed rewarming thrombocytopenia. Although this is typically a concern at temperatures deeper than most cold sepsis cases reach, it illustrates why gradual controlled rewarming is preferred over rapid correction.

Coagulopathy in general, meaning disordered clotting, is already a hallmark of severe sepsis. Adding hypothermia worsens the clotting cascade’s function and complicates lab interpretation, since standard coagulation tests are run at 37°C and may not reflect what is actually happening in a cold patient’s blood.

Temperature Monitoring Is Harder Than It Sounds

Getting an accurate temperature reading in a critically ill patient matters enormously when the threshold between “normal” and “hypothermic” is only a degree or two below normal. Yet not all thermometers are created equal. A systematic review of temperature measurement methods in ICU patients found that axillary, tympanic, and zero-heat-flux thermometers all tended to underestimate true core temperature compared to intravascular measurements. Only esophageal probes showed clinically acceptable accuracy.

In a busy emergency department, an armpit temperature of 36.1°C might look normal enough to dismiss, when the true core value is closer to 35.5°C. This measurement gap is another reason cold sepsis can fly under the radar. It also means that for patients in septic shock, clinicians often need to rely on core temperature devices rather than the quick methods used during triage.

Catching It Before It Reaches the Hospital

For cold sepsis, the timeline between symptom onset and treatment start is crucial but often extended because the presentation is not dramatic. Paramedics are increasingly trained to screen for sepsis in the field, but their sensitivity for identifying sepsis is around 73%, meaning roughly one in four cases gets missed at first contact. When the patient is cold instead of feverish, those miss rates are likely even higher, though the study did not break results out by temperature presentation.

For families and caregivers, understanding that cold skin, confusion, and lethargy in someone with an underlying infection can signal sepsis is genuinely life-saving knowledge. The instinct to wait for a fever before seeking emergency care can cost critical hours. If an elderly parent or very young infant with a known or suspected infection is cool to the touch, not making sense, or seems unusually limp and unresponsive, that warrants an emergency call regardless of the thermometer reading.

Life After Cold Sepsis

Surviving sepsis of any kind does not mean the ordeal is over. Post-sepsis syndrome is a well-documented constellation of physical, cognitive, and psychological problems that can persist for months or years after hospital discharge. Survivors face higher rates of hospital readmission and reduced life expectancy. In follow-up studies, the prevalence of post-sepsis syndrome remained strikingly high, affecting roughly 61% to 78% of survivors at one and three months after discharge.

Common lingering effects include chronic fatigue, muscle weakness, difficulty concentrating (sometimes described as “brain fog”), anxiety, depression, and increased vulnerability to new infections. Given that cold sepsis patients tend to be older, more frail, or more immunocompromised to begin with, their recovery trajectory can be particularly slow. Rehabilitation, follow-up with primary care, and mental health support are all important parts of the path back, yet many survivors report receiving little guidance on what to expect once they leave the hospital.

Why Cold Sepsis Remains Understudied

Despite its higher mortality, hypothermic sepsis has received far less research attention than febrile sepsis. One reason is practical: most clinical trials of sepsis therapies enroll patients who meet standard screening criteria, which are weighted toward detecting fever and hypotension. Cold sepsis patients may not trigger screening tools quickly enough to be enrolled early, or they may be excluded from trials because their presentation muddies the inclusion criteria. The heterogeneity of sepsis itself is a recognized barrier to effective clinical research, with any given cohort containing subgroups suffering different levels of inflammation and immune suppression in different organs. Hypothermic patients likely represent a particularly distinct subgroup within that complexity, yet they are rarely analyzed separately in large trials.

Emerging tools like infrared thermography for measuring core-to-peripheral temperature gradients are promising for early identification and risk stratification, but they are far from widespread use. Until screening protocols explicitly account for the possibility that sepsis can present cold, this form will continue to be diagnosed later, treated later, and studied less than it deserves.